Northwest Biotherapeutics (NWBO) Short Interest Ratio & Short Volume → I’m afraid WWIII is a very real possibility (From Porter & Company) (Ad) Free NWBO Stock Alerts $0.47 -0.01 (-2.10%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Northwest Biotherapeutics Short Interest DataCurrent Short Volume49,284,100 sharesPrevious Short Volume47,695,000 sharesChange Vs. Previous Month+3.33%Dollar Volume Sold Short$22.92 millionShort Interest Ratio / Days to Cover18.5Last Record DateApril 30, 2024Outstanding Shares1,210,880,000 sharesPercentage of Shares Shorted4.07%Today's Trading Volume1,145,477 sharesAverage Trading Volume1,707,619 sharesToday's Volume Vs. Average67% Short Selling Northwest Biotherapeutics ? Sign up to receive the latest short interest report for Northwest Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNWBO Short Interest Over TimeNWBO Days to Cover Over TimeNWBO Percentage of Float Shorted Over Time Ad The Freeport SocietyPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. Northwest Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202449,284,100 shares $22.92 million +3.3%N/A18.5 $0.47 4/15/202447,695,000 shares $23.94 million +4.0%N/A17 $0.50 3/31/202445,844,600 shares $23.79 million +0.8%N/A9.3 $0.52 3/15/202445,479,700 shares $23.97 million +0.5%N/A17.1 $0.53 2/29/202445,237,600 shares $24.83 million +0.8%N/A13.2 $0.55 2/15/202444,861,300 shares $25.08 million -1.5%N/A12.3 $0.56 Get the Latest News and Ratings for NWBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202445,906,000 shares $29.27 million -0.5%N/A14 $0.64 12/31/202346,139,800 shares $32.34 million +0.8%N/A11.1 $0.70 12/15/202345,776,800 shares $33.87 million -1.9%N/A19.9 $0.74 11/30/202346,647,900 shares $35.45 million -5.3%N/A15.3 $0.76 11/15/202349,260,600 shares $41.50 million -11.6%N/A10.1 $0.84 10/31/202355,750,400 shares $42.93 million +2.8%N/A18.6 $0.77 10/15/202354,229,800 shares $37.36 million +3.6%N/A12.2 $0.69 9/30/202352,330,400 shares $47.60 million +2.7%N/A5.3 $0.91 9/15/202350,976,500 shares $35.00 million +4.2%N/A12.1 $0.69 8/31/202348,940,600 shares $28.15 million +3.1%N/A8.8 $0.58 8/15/202347,481,100 shares $23.42 million +5.5%N/A15.5 $0.49 7/31/202344,998,100 shares $23.83 million +1.6%N/A16.9 $0.53 7/15/202344,299,500 shares $24.67 million +2.3%N/A18.4 $0.56 6/30/202343,316,900 shares $24.60 million +3.2%N/A17.2 $0.57 6/15/202341,973,700 shares $27.29 million +3.0%N/A10.9 $0.65 5/31/202340,738,000 shares $24.44 million +2.2%N/A18.7 $0.60 5/15/202339,849,500 shares $24.49 million +6.5%N/A12.7 $0.61 4/30/202337,419,400 shares $18.71 million -4.7%N/A8.9 $0.50 4/15/202339,268,700 shares $21.05 million +0.3%N/A12 $0.54 3/31/202339,133,700 shares $24.46 million -0.3%N/A10 $0.63 3/15/202339,268,200 shares $22.97 million -2.2%N/A15.8 $0.59 2/28/202340,154,000 shares $26.30 million +2.8%N/A14.6 $0.66 2/15/202339,064,000 shares $26.76 million +0.9%N/A9.4 $0.69 1/31/202338,719,500 shares $27.34 million -6.3%N/A12.7 $0.71 1/15/202341,300,600 shares $30.15 million -1.4%N/A9.5 $0.73 12/30/202241,886,300 shares $32.86 million +0.3%N/A11.1 $0.78 12/15/202241,783,300 shares $37.02 million +8.3%N/A6.9 $0.89 11/30/202238,579,900 shares $32.37 million +40.5%N/A2.9 $0.84 11/15/202227,453,900 shares $25.88 million +0.4%N/A5.8 $0.94 10/31/202227,335,600 shares $20.67 million -0.7%N/A11.8 $0.76 10/15/202227,532,400 shares $18.56 million -1.7%N/A13.6 $0.67 9/30/202228,010,900 shares $20.00 million -3.6%N/A12.2 $0.71 9/15/202229,057,900 shares $21.65 million -4.7%N/A9.1 $0.75 8/31/202230,503,400 shares $21.20 million -2.9%N/A7.8 $0.70CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. NWBO Short Interest - Frequently Asked Questions What is Northwest Biotherapeutics' current short interest? Short interest is the volume of Northwest Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 49,284,100 shares of NWBO short. Learn More on Northwest Biotherapeutics' current short interest. What is a good short interest ratio for Northwest Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NWBO shares currently have a short interest ratio of 18.0. Learn More on Northwest Biotherapeutics's short interest ratio. Is Northwest Biotherapeutics' short interest increasing or decreasing? Northwest Biotherapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 49,284,100 shares, an increase of 3.3% from the previous total of 47,695,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Northwest Biotherapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Northwest Biotherapeutics: Astria Therapeutics, Inc. (10.24%), Arbutus Biopharma Co. (3.08%), Applied Therapeutics, Inc. (3.91%), COMPASS Pathways plc (4.99%), Avid Bioservices, Inc. (17.42%), Basilea Pharmaceutica AG (0.72%), Larimar Therapeutics, Inc. (6.11%), Verve Therapeutics, Inc. (30.19%), Altimmune, Inc. (31.47%), KalVista Pharmaceuticals, Inc. (13.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Northwest Biotherapeutics stock? Short selling NWBO is an investing strategy that aims to generate trading profit from Northwest Biotherapeutics as its price is falling. NWBO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Northwest Biotherapeutics? A short squeeze for Northwest Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NWBO, which in turn drives the price of the stock up even further. How often is Northwest Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWBO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: STOK Short Interest Data PHAT Short Interest Data ORIC Short Interest Data PHGUF Short Interest Data CDMO Short Interest Data SLN Short Interest Data HROW Short Interest Data SVRA Short Interest Data OLMA Short Interest Data LYEL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWBO) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace